The application of low dose phenobarbital (PHP) in the treatment of sympathetic hyperactive self depression

摘要

The invention relates to a drug. The invention describes a new application of phenobarbital in the treatment of automatic tissue disorder. The short-term treatment slowed down the sympathetic hyperactivity found in the sympathetic stimulation test, the improvement of clinical function and the reduction of sympathetic hyperactivity. The latter was objectified by the low-dose phenobarbital sympathetic simulation test.The new pharmacological prescription can reduce the intensity of functional symptoms of patients, mainly neurovascular and cardiovascular, especially can produce central antisense effect. The invention provides a new drug dosage, which is used for treating the self-regulation disorder with the type of sympathetic hperactive. Between 0.5 and 1 mg / kg and/The invention also relates to the preventive treatment of gene susceptibility to HTA under the high sympathetic response to HTA after simulating the central sympathetic system. Or, despite normal PA () blood pressure under the basic conditions of the World Health Organization (who), in the presence of a positive vein HTA ("peripheral sympathetic hyperactivity").